Abstract-Recently it has been demonstrated that catecholamines are produced and used by macrophages and mediate immune response. The aim of this study is to verify whether endothelial cells (ECs), which are of myeloid origin, can produce catecholamines. We demonstrated that genes coding for tyrosine hydroxylase, Dopa decarboxylase, dopamine ␤ hydroxylase (D␤H), and phenylethanolamine-N-methyl transferase, enzymes involved in the synthesis of catecholamines, are all expressed in basal conditions in bovine aorta ECs, and their expression is enhanced in response to hypoxia. Moreover, hypoxia enhances catecholamine release. To evaluate the signal transduction pathway that regulates catecholamine synthesis in ECs, we overexpressed in bovine aorta ECs either protein kinase A (PKA) or the transcription factor cAMP response element binding, because PKA/cAMP response element binding activation induces tyrosine hydroxylase transcription and activity in response to stress. Both cAMP response element binding and PKA overexpression enhance D␤H and phenylethanolamine-N-methyl transferase gene expression and catecholamine release, whereas H89, inhibitor of PKA, exerts the opposite effect, evidencing the role of PKA/cAMP response element binding transduction pathway in the regulation of catecholamine release in bovine aorta ECs. We then evaluated by immunohistochemistry the expression of tyrosine hydroxylase, Dopa decarboxylase, D␤H, and phenylethanolamine-N-methyl transferase in femoral arteries from hindlimbs of C57Bl/6 mice 3 days after removal of the common femoral artery to induce chronic ischemia. Ischemia evokes tyrosine hydroxylase, Dopa decarboxylase, D␤H, and phenylethanolamine-N-methyl transferase expression in the endothelium. Finally, the pharmacological inhibition of catecholamine release by fusaric acid, an inhibitor of D␤H, reduces the ability of ECs to form network-like structures on Matrigel matrix. In conclusion, our study demonstrates for the first time that ECs are able to synthesize and release catecholamines in response to ischemia. Key Words: catecholamines Ⅲ ischemia Ⅲ endothelium Ⅲ angiogenesis E ndothelial cells (ECs) cover the interior surface of blood vessels throughout the entire circulatory system, and they are involved in many aspects of vascular biology.
ndothelial cells (ECs) cover the interior surface of blood vessels throughout the entire circulatory system, and they are involved in many aspects of vascular biology. [1] [2] [3] [4] Indeed, angiogenesis is a phenomenon intimately associated with EC migration and proliferation during embryonic development. 5 Similarly, ECs play major roles in immune and inflammatory reactions by regulating lymphocyte and leukocyte migration into tissues by means of direct interaction with ECs. 6 Moreover, ECs have an important role in the regulation of the vascular tone by releasing vasoactive agents controlling smooth muscle cell proliferation and contractility.
Indeed, ECs are known to release both vasodilators (NO) and vasoconstrictors (thromboxane, platelet-derived growth factor, and endothelin 1) in response to local and circulating stimuli. [7] [8] [9] [10] [11] [12] [13] [14] To this purpose, the endothelium is regulated in a fine way by a series of receptors that are expressed on its surface, including adrenergic receptors (ARs), such as ␣ 1 and ␤ 2 AR. 15, 16 Circulating catecholamines are thought to be the natural agonist of these receptors, giving the fact that ECs are not reached by sympathetic innervation. 1 The endothelium derives from the embrional mesenchimal sheet, so it does the population of myeloid lineage-restricted bone marrow progenitors. 17 The common features between the 2 lineages are suggested by the observation that endothelial progenitors are released in the bloodstream from bone marrow myelocytic progenitors. 18 This finding is consistent with results from several laboratories that have reported circulating cells with myeloid features contributing to human angiogenesis. [19] [20] [21] [22] Circulating catecholamines, dopamine, norepinephrine (NE), and epinephrine (EPI), regulate vascular tone via ␣AR activation, leading to vasoconstriction in most systemic arteries and veins. They are synthesized from the amino acid precursor l-tyrosine. Tyrosine hydroxylase (TH) is the first rate-limiting enzyme in catecholamine synthesis that catalyzes the conversion of tyrosine to l-dihydroxyphenylalanine. This latter is converted to dopamine by Dopa decarboxylase (DDC). On turn, dopamine is converted to NE by dopamine ␤ hydroxylase (D␤H), and NE is converted to EPI by phenylethanolamine-N-methyl transferase (PNMT). [23] [24] [25] [26] Once released, catecholamines are quickly inactivated by 2 enzymes that are responsible for their catabolism, catecholoxymethyltransferase and monoamine oxidase. 27, 28 Monoamine oxidase catalyzes the oxidative deamination of amines, and catechol-oxymethyltransferase methylates the hydroxyl group meta to the side chain of catecholamines. 29 Until a few years ago, catecholamines were considered mainly as conventional neurotransmitters and neuroendocrine mediators, synthesized in the adrenal medulla. However, it has been demonstrated recently that they are also produced and used by cells of the immune system. [30] [31] [32] [33] [34] [35] [36] Indeed, catecholamines are actively produced by macrophages and have the capacity to act in an autocrine way on ARs to regulate macrophage production of interleukin 1␤, which has a key role in the inflammatory response. 37 Giving the common myeloid origin of ECs and macrophages and the ability of cells of the immune system to produce catecholamines, the aim of this study was to verify whether ECs were also able to autonomously synthesize and release catecholamines for signaling purposes.
Materials and Methods
All of the experiments were performed as described previously. 38 Extended details of Methods are described in the online-only Data Supplement.
Results

ECs Produce Catecholamines
To assess the ability of ECs to synthesize catecholamines, we first evaluated the expression of genes coding for the enzymes involved in the synthesis of catecholamines by realtime RT-PCR both in basal conditions and in response to hypoxia. We performed a time course experiment evaluating enzyme gene expression at 1, 3, 6, 16, and 24 hours of hypoxia ( Figure 1A ). Hypoxia-induced TH, DDC, D␤H, and PNMT gene expressions respect to basal conditions in a time-dependent manner. At 16 hours of hypoxia, we found the maximum expression of these enzymes, and then cells start to die. Based on such data, we chose to incubate cells in hypoxic conditions for 16 hours, because it is an intermediate time between enzyme maximum expression and cell death. We confirmed this result by Western blot analysis. Figure 1B shows that hypoxia increased protein levels of TH, DDC, D␤H, and PNMT in whole cell lysates. Total lysate from mouse adrenal glands and spleens were used, respectively, as positive and negative controls. We also verified enzyme expression in bovine aorta ECs by immunohistochemistry. TH, DDC, D␤H, and PNMT were all expressed in basal condition, and their expression was enhanced by hypoxic stimulus ( Figure S1 , available in the online-only Data Supplement). Immunohistochemistry shows that DDC, D␤H, and PNMT presented a cytosolic and perinuclear localization, whereas TH was mainly localized in the nucleus. Finally, to confirm the ability of bovine aorta ECs (BAECs) to produce catecholamines, we analyzed NE and EPI release in the culture medium by ELISA assay ( Figure 1C ). Hypoxia enhanced both NE and EPI release with respect to normoxia.
Hypoxia Regulates Catecholamine Synthesis in EC by Activation of Protein Kinase A/cAMP Response Element Binding Signaling
To assess the signal transduction pathway that regulates catecholamine synthesis in ECs, we evaluated protein kinase A (PKA) signaling, because it is known that PKA/cAMP response element binding (CREB) activation induces TH transcription and activity in response to stress. 39, 40 We first analyzed by Western blot the effect of hypoxia on the activation of CREB and PKA. Figure 2A shows that hypoxia induces the expression of the phosphorylated and activated forms of both CREB and PKA, confirming that, also in BAECs, hypoxia regulates PKA/CREB signaling. Based on such data, we evaluated whether hypoxia-induced PKA/ CREB activation regulates catecholamine synthesis in BAECs. In these experiments, we focused on D␤H and PNMT expression, being the key enzymes for NE and EPI synthesis. To assess whether this signaling was involved in the regulation of catecholamine synthesis, we pharmacologically inhibited PKA/CREB signaling using a selective inhibitor of PKA, H89. This latter inhibited hypoxia induced D␤H and PNMT gene expression (D␤H, Ϫ73.7Ϯ0.03% and PNMT, Ϫ75.2Ϯ0.04% versus hypoxia; Figure 2B ) and prevented hypoxia-evoked increase of D␤H and PNMT protein levels ( Figure 2C ). To further confirm these data, we used a peptidic inhibitor of PKA (PKA-I), which is more specific and selective respect to H89. PKA-I reduced both D␤H and PNMT protein levels in response to hypoxia ( Figure 2D ). These data demonstrate that, in BAECs, hypoxia induces PKA/CREB signaling, and the activation of this pathway regulates catecholamine synthesis. To confirm these results, we overexpressed in BAECs both PKA and CREB by means of transient transfection. Both CREB and PKA overexpression enhanced D␤H (CREB, ϩ2.1Ϯ0.09; PKA, ϩ6Ϯ2.01-fold of basal) and PNMT (CREB, ϩ9.8Ϯ0.3; PKA, ϩ5.6Ϯ1.7-fold of basal) gene expression in basal conditions ( Figure 2E ). PKA overexpression further enhanced the response to hypoxia (D␤H ϩ16Ϯ0.6 and PNMT ϩ9.6Ϯ0.2 versus hypoxia; Figure 2E ). Accordingly, Western blot analysis showed that CREB and PKA overexpression increased D␤H and PNMT protein levels, and PKA overexpression Results are the mean of 5 independent experiments. B, e, normoxia; , hypoxia; horizontal stripe, hypoxiaϩH89. D, To confirm the involvement of PKA in this phenomenon, we inhibited PKA activity by means of a peptidic inhibitor that is more selective and specific respect to H89, peptidic inhibitor of PKA (PKA-I). PKA-I inhibits both D␤H and PNMT protein levels in response to hypoxia. Actin was used as loading control. E and F, To confirm these data, we overexpressed in cells CREB and PKA by transient transfection and analyzed D␤H and PNMT levels. Both CREB and PKA overexpression increase D␤H and PNMT gene expression (E) and protein levels (F) both in basal condition and in response to hypoxia. Actin was used as loading control for Western blot analysis; *PϽ0.05 vs normoxia, #PϽ0.05 vs hypoxia. Images are representative of 3 independent experiments. E, e, basal; s, CREB; , PKA; vertical lines, hypoxia; o, hypoxiaϩCREB; dots, hypoxiaϩPKA.
further increased the response to hypoxia ( Figure 2F ). Moreover, PKA/CREB signaling also regulated catecholamine release in the culture medium ( Figure S2 ). Indeed, H89 inhibited hypoxia-induced NE ( Figure S2A ) and EPI ( Figure  S2B ) release. CREB overexpression caused NE ( Figure S2C ) and EPI ( Figure S2D ) release. In these conditions, hypoxia was no longer able to induce further accumulation ( Figure  S2C and S2D) . Also, PKA overexpression increased catecholamine release ( Figure S2C and S2D), and in these cells hypoxia was still able to induce a modest increase of catecholamine release. These data indicate that hypoxiainduced activation of the PKA/CREB signaling transduction pathway regulates catecholamine synthesis and release in BAECs.
Endothelium Produces Catecholamines In Vivo
To confirm in vitro data, we evaluated in vivo by immunohistochemistry the expression of TH, DDC, D␤H, and PNMT in superficial femoral arteries from hindlimbs of C57Bl/6 mice 3 days after surgery. Ischemia induced DDC, D␤H, and PNMT expression in the endothelium of femoral arteries ( Figure 3A ) and in capillaries, highlighted in the femoral muscle by lectin staining ( Figure 3B ). On the contrary, TH was maximally expressed in the cytoplasm of muscle cells, although a higher magnification also revealed an endothelial localization. Negative control with secondary antibody only was shown in Figure S3 .
Endothelium-Dependent Catecholamine Release Has a Key Role in Angiogenesis In Vitro
To evaluate the physiopathological role of endotheliumdependent catecholamine release in vitro, we evaluated the ability of BAECs to form network-like structures on Matrigel matrix in the presence or absence of a selective inhibitor of D␤H, fusaric acid (FA). Figure S4 shows that hypoxia induced vascular network formation and FA inhibited the response to hypoxia ( Figure S4A ). To confirm that the effect of FA on angiogenesis is ascribed to its ability to inhibit catecholamine release, we evaluated NE and EPI release in the culture medium by ELISA assay (Figure S4B and S4C) . FA inhibited hypoxia-dependent catecholamine release (NE, Ϫ32Ϯ1.7%; EPI, Ϫ37Ϯ2.1% versus hypoxia). These data suggest that ECs autonomously produce catecholamines that have a key role in the regulation of EC proangiogenic responses. To avoid the possibility that FA-dependent inhibition of angiogenesis in vitro was attributed to a toxic effect of the drug, we performed a proliferation assay using different dosages of FA. FA turned out to be not toxic for cells at doses from 10 nmol/L to Յ500 mol/L (data not shown).
␤ 2 AR Is Involved in Catecholamine-Induced Angiogenesis in BAECs
We have demonstrated previously that ␤ 2 AR has a key role in angiogenesis both in vitro and in vivo. 16, 41 In particular, we demonstrated in vivo that ␤ 2 AR regulates angiogenesis in vivo in response to ischemia, because angiogenesis is impaired in ␤ 2 AR knockout mice and is ameliorated by reinstatement of ␤ 2 AR. Here we tested this effect also on hypoxia-induced angiogenesis in BAECs. To this aim we performed a real-time PCR analysis to evaluate the effect of ␤ 2 AR inhibition by the selective inhibitor ICI 118.551 on vascular endothelial growth factor gene expression. Our data show that ␤ 2 AR blockade is able to reduce vascular endothelial growth factor expression induced by hypoxia ( Figure 4A ), suggesting a key role for this receptor in catecholamine-induced angiogenesis in response to hypoxia. Furthermore, we evaluated whether catecholamine-induced ␤ 2 AR-dependent angiogenesis could, in turn, be regulated by ␤ 2 AR itself. To this aim, we performed a real-time PCR experiment to evaluate D␤H and PNMT gene expression in cells with selective blockade of ␤ 2 AR by ICI 118.551. The blockade of ␤ 2 AR inhibited both D␤H ( Figure 4B ) and PNMT ( Figure 4C ) gene expression in response to hypoxia. These data suggest that catecholamines from ECs could promote their own synthesis in a paracrine positive feedback manner by means of ␤ 2 AR activation.
Discussion
We report here, for the first time, that ECs are capable of synthesizing catecholamines because they have the complete intracellular machinery for the generation and release of NE and EPI. In vitro, ECs expressed all of the enzymes involved in the synthesis of catecholamines in basal conditions, and this expression is enhanced in response to hypoxia. We also identified the molecular mechanism that regulates this phenomenon. Indeed, we demonstrated that hypoxia-induced catecholamine release in the culture medium is regulated by the activation of PKA/CREB signaling, which is already known to regulate most important endothelial functions, such as endothelial NO synthase gene transcriptional activation. 42 These results are paralleled by data from an in vivo model of chronic ischemia, where we demonstrate that TH, DDC, D␤H, and PNMT are expressed in the endothelium of the femoral artery. TH expression in endothelium, despite the other enzymes, is difficult to detect at low magnification and needs a higher enlargement. This is because of the nuclear localization of TH in BAECs, as demonstrated by immunohistochemical analysis (Figure S1 ), which is difficult to detect in vivo in capillaries. Moreover, the nuclear staining is masked by hematoxylin counterstain. This nuclear localization of TH is suggested also by other reports, in human epidermal melanocytes 43 and in perikarya of rat ventral tegmental area. 44 Our in vivo results also show that TH is localized in the cytoplasm of muscle cells, and it was never described before. However, further experiments are needed to clarify this aspect.
ECs play a critical role in the control of vascular function because they participate in all aspects of vascular homeostasis but also in physiological or pathological processes like vascular wall remodeling, inflammation, or thrombosis. In particular, they have a key role in angiogenesis, in coagulation and fibrinolysis, and in the regulation of vascular tone, as well as in inflammatory reactions and in tumor neoangiogenesis. [45] [46] [47] [48] [49] [50] ECs are capable of synthesizing and releasing a variety of substances that may exert autocrine, paracrine, or endocrine effects. Indeed, they contribute to the regulation of blood pressure and blood flow by releasing vasodilators such as NO and prostacyclin, as well as vasoconstrictors, including endothelin and platelet-activating factor, in response to stimuli. 14, 51, 52 Given the evidence that ischemia enhances plasma levels of NE, 53 it has been shown recently that catecholamines contribute to arteriogenesis and angiogenesis in pathological conditions such as hindlimb ischemia 54 and that they contribute to angiogenesis in the wound-healing process. 55 Based on our and previous data, we hypothesize that the ability of ECs to synthesize and release catecholamines is an autoregulatory physiological mechanism in response to hypoxia to induce neovascularization. Indeed, the inhibition of catecholamine release by FA reduced the proangiogenic phenotype of ECs in vitro. This finding puts the ARs on ECs in a different perspective. Indeed, the lack of terminal innervations on ECs has sustained the concept that circulating catecholamines are the natural stimulants to endothelial ARs. Our data allow for the promoting of a new scenario in which ECs produce catecholamines that act in a paracrine way to sustain proangiogenic phenotypes in conditions such as ischemia ( Figure 4D ). Furthermore, these data are well in agreement with previous reports showing the ability of ECs to produce catecholamine catabolism enzymes, such as monoamine oxidase and catechol-oxymethyltransferase. 56 We have identified previously the ␤ 2 AR as the adrenergic receptor involved in the regulation of angiogenesis in ECs. 16, 41 Here we demonstrated that ␤ 2 AR is activated by catecholamines released by ECs to induce angiogenesis, and it, in turn, regulates catecholamines release. A future direction of research will address the signaling linking hypoxia and PKA/CREB activation given the potential role of this pathway in the activation of the endothelium. In conclusion, our study demonstrates for the first time the ability of ECs to synthesize and release catecholamines in response to hypoxia (in vitro) and ischemia (in vivo) and the involvement of this phenomenon in the regulation of angiogenesis.
Perspectives
Our data indicate ECs as a source of catecholamine synthesis and release. This is a further advance in the understanding of endothelial function and physiology that could be useful to
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determine targeted therapies for many diseases, including cancer, cardiovascular disease, and inflammatory conditions. BAECs were treated with ICI 118.551, 100 nmol/L, for 30 minutes and incubated in the hypoxic chamber for 16 hours. A through C, RNA from BAECs was converted to cDNA and analyzed by real-time PCR to evaluate the expression of vascular endothelial growth factor (VEGF; A), dopamine ␤ hydroxylase (D␤H; B), and phenylethanolamine-N-methyl transferase (PNMT; C) in response to hypoxia. All of the enzymes are expressed in basal conditions, and hypoxia enhanced their expression. ICI inhibits basal gene expression and reduces the response to hypoxia; *PϽ0.05 vs normoxia, #PϽ0.05 vs hypoxia. Results are the mean of 5 independent experiments. e, control (CTRL); , hypoxia. D, Schematic summary of our results: in endothelial cells, ischemia activates induced protein kinase A (PKA)/cAMP response element binding (CREB) signaling inducing the transcription of genes coding for tyrosine hydroxylase (TH), Dopa decarboxylase (DDC), D␤H, and PNMT. All of these enzymes participate in catecholamine synthesis. Norepinephrine (NE) and epinephrine (EPI) are then released and act in a paracrine way on ␤2 adrenergic receptors to promote VEGF production and angiogenesis. The enzymes catechol-oxymethyltransferase (COMT) and monoamine oxidase (MAO) regulate catecholamine catabolism. 
Novelty and Significance
What Is New?
• ECs respond to stress-releasing catecholamines. These catecholamines stimulate receptors on EC accelerating regenerating processes, such as angiogenesis.
What Is Relevant?
• Endothelial dysfunction seen in hypertension might alter the ability of ECs to release catecholamines in response to stress. This impairment alters the ability of ECs to adapt to conditions such as ischemia or inflammation.
Summary
We demonstrate that ECs present the enzymes to produce and release NE and EPI, in response to ischemia. These substances, in turn, further sustain the activation of endothelial function, such as angiogenesis.
